S. Carballo

Discipline

Psychologie (2) Economies et finances (1)

Type de document

Articles (10)

Co-auteur

Date

Source

Mot-clé

Patients (10) Patients (10) Syndromes (6) risque (5) âge (5) taux (5) Treatment (5) Risk (5) Age (5) Age (5) cohorte (5) Year (4) Ci (Chinese poetry) (4) thérapie (3) mortalité (3) procès (3) Mortality (3) Care (3) Death (3) Methods (3) Rates (3) Weights and measures (3) Therapeutics (3) Swiss (3) Mortality (3) Human beings (3) University hospitals (3) Myocardial infarction (3) Death (3) Days (3)

Documents écrit par S. Carballo (10) | parle de S. Carballo (0)

Symptoms and quality of life at 1-year follow up of patients discharged after an acute COVID-19 episode.
E. Tessitore et al. (6 déc. 2021)
Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse events.
R. Klingenberg et al.
Non-Linear Relationship between Anti-Apolipoprotein A-1 IgGs and Cardiovascular Outcomes in Patients with Acute Coronary Syndromes.
N. Vuilleumier et al. (9 juil. 2019)
Clinical impact of a structured secondary cardiovascular prevention program following acute coronary syndromes: A prospective multicenter healthcare intervention.
D. Carballo et al. (2019)
Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Acute Coronary Syndromes.
B. Gencer et al. (9 nov. 2017)
Predictors and Implications of Early Clinical Stability in Patients Hospitalized for Moderately Severe Community-Acquired Pneumonia.
N. Garin et al. (2016)
Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study.
D. Carballo et al. (2015)
β-Lactam Monotherapy vs β-Lactam-Macrolide Combination Treatment in Moderately Severe Community-Acquired Pneumonia: A Randomized Noninferiority Trial.
N. Garin et al. (2014)
Acute respiratory and cardiovascular admissions after a public smoking ban in geneva, Switzerland.
J.P. Humair et al. (2014)
Quality of care after acute coronary syndromes in a prospective cohort with reasons for non-prescription of recommended medications.
R. Auer et al. (2014)